Minas Gerais, Brazil

Rafaella Queiroz

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: University of Georgia Research Foundation Inc. Active years: 2017-2025.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Rafaella Queiroz in Vaccine Delivery Methods

Introduction

Rafaella Queiroz is an accomplished inventor based in Minas Gerais, Brazil. She has made significant contributions to the field of vaccine delivery, holding three patents that showcase her innovative approach to immunization methods.

Latest Patents

One of her notable patents is a vaccine delivery method that includes a composition featuring a slurry matrix. This matrix is a liquid at room temperature and transforms into a gel at physiological pH, physiological salt concentrations, and/or physiological temperatures. The second component of this composition consists of one or more antigens. The patent also outlines methods for inducing an immune response in a subject and vaccinating a subject by administering such compositions.

Career Highlights

Rafaella Queiroz is affiliated with the University of Georgia Research Foundation, Inc., where she continues to advance her research in vaccine delivery systems. Her work is pivotal in enhancing the effectiveness of vaccines, which is crucial for public health.

Collaborations

Rafaella collaborates with esteemed colleagues, including Donald A. Harn, Jr. and Lisa Shollenberger, who contribute to her research endeavors and help in the development of innovative solutions in the field of immunology.

Conclusion

Rafaella Queiroz's contributions to vaccine delivery methods exemplify her dedication to improving healthcare through innovation. Her patents reflect a commitment to advancing medical science and enhancing the efficacy of vaccines.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…